Synthivan Tablet is a combination of two antiretroviral medicines containing Atanazavir and Ritonavir. Synthivan Tablet is used to treat Human Immunodeficiency Virus (HIV) infection in adults and pediatric patients at least 6 years of age and weighing 35 kg. Synthivan Tablet helps control HIV Infection and prevent the development of acquired immunodeficiency syndrome (AIDS).
Synthivan Tablet does not completely cure HIV Infection. Synthivan Tablet will reduce the progression of a chronic potentially life-threatening condition known as acquired immunodeficiency syndrome (AIDS) and other HIV-related conditions. Synthivan Tablet will work by stopping the virus from multiplying in the body.
Synthivan Tablet may not be suitable for every patient. Synthivan Tablet is not recommended for patients weighing less than 35 kg. If you have any skin-related problems, liver disease, kidney disease, heart problems, high blood pressure, or diabetes, or if you are overweight any other health-related problems please consult your doctor before the treatment.
Before taking Synthivan Tablet talk to your doctor about the potential risks and benefits of taking this medication, as well as any other questions or concerns you may have and also important to let your doctor you have any pre-existing diseases or using any medications, vitamins supplements, herbal medicine you are taking.
Synthivan Tablet should be taken with or without food daily once. It is important to follow your doctor's instructions for taking Synthivan Tablet and to continue taking the medication as prescribed even if you feel well. Do not stop taking Synthivan Tablet or change your dosage without first consulting your doctor.
Human Immunodeficiency Virus Infection (HIV): Synthivan Tablet medicine is used in the treatment of human immunodeficiency (HIV) virus infection that attacks and weakens the immune system. It is spread through contact with certain bodily fluids, such as blood, semen, vaginal fluids, and breast milk, from an infected person.
The main benefit of taking Synthivan Tablet helps to reduce the amount of HIV virus in the blood (viral load) and improve immune function and also helps to reduce the progression of HIV infection and reduce the risk of developing complications, such as AIDS.
Taking Synthivan Tablet has a low risk of side effects compared to some other HIV medications. It is also easy to take, as it only needs to be taken once daily with food.
Synthivan Tablet can help reduce the risk of transmitting HIV to others. Synthivan Tablet can help suppress the virus and reduce the amount of HIV in the body.
As with all medicines, Synthivan Tablet may cause side effects which do not require medical attention and which will disappear as your body adjusts to the medicine. If they persist or you're concerned about them, tell your doctor.
It is recommended that you take Synthivan Tablet with a full glass of water. It can be taken with or without eating, depending on how you feel. However, make sure you follow the prescribed dosage exactly as prescribed by your doctor. Avoid taking more or less than directed. If you forget to take a dose of Synthivan Tablet, take it as soon as you remember. If you miss a dose, skip the miss dose and resume your usual dosing schedule. Taking two doses at the same time to compensate for a missed dose is not recommended. You can crush Benefits of Synthivan Tablet and mix it with a small amount of food or liquid before taking it if you have difficulty swallowing tablets.
Synthivan Tablet is a combination of two antiretroviral medicines containing Atanazavir and Ritonavir. Both are protease inhibitors Atanazavir works by blocking the action of protease enzyme, as needed by the HIV virus to replicate and spread in the body. Ritonavir works by helping to boost the levels of atazanavir in the body, making it more effective at reducing the amount of HIV virus in the blood (viral load).
It is not recommended to breastfeed while taking Synthivan Tablet. Synthivan Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Synthivan Tablet, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for your and your baby's health
Use of Synthivan Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Synthivan Tablet during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Synthivan Tablet is safe to use in patients with kidney disease. No dose adjustment of Synthivan Tablet is recommended. If you experience any side effects please consult your doctor.
It is generally not recommended to drink alcohol while taking Synthivan Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Synthivan Tablet should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Synthivan Tablet and report any unusual symptoms or changes in liver function to their doctor. The dose of Synthivan Tablet may need to be adjusted in patients with liver disease.
Synthivan Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Synthivan Tablet.
1. Atazanavir Sulfate And Ritonavir Tablets, 300 Mg/100 Mg, Matrix Laboratories Limited, India, Product Leaflet
2. Atazanavir (as Sulfate)/ritonavir 300 Mg/100 Mg Tablets, Cipla Ltd. India Product Monograph
3. Atazanavir/ritonavir-based combination antiretroviral therapy for the treatment of HIV-1 infection in adults, National Institute Of Library (NIH), Available form